Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly- l -glutamate/glutamine cell wall structure, and bacterial replication
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
New antibiotics to combat the emerging pandemic of drug-resistant strains of Mycobacterium tuberculosis are urgently needed. We have investigated the effects on M. tuberculosis of phosphorothioate-modified antisense oligodeoxyribonucleotides (PS-ODNs) against the mRNA of glutamine synthetase, an enzyme whose export is associated with pathogenicity and with the formation of a poly- l -glutamate/glutamine cell wall structure. Treatment of virulent M. tuberculosis with 10 μM antisense PS-ODNs reduced glutamine synthetase activity and expression by 25–50% depending on whether one, two, or three different PS-ODNs were used and the PS-ODNs' specific target sites on the mRNA. Treatment with PS-ODNs of a recombinant strain of Mycobacterium smegmatis expressing M. tuberculosis glutamine synthetase selectively inhibited the recombinant enzyme but not the endogenous enzyme for which the mRNA transcript was mismatched by 2–4 nt. Treatment of M. tuberculosis with the antisense PS-ODNs also reduced the amount of poly- l -glutamate/glutamine in the cell wall by 24%. Finally, treatment with antisense PS-ODNs reduced M. tuberculosis growth by 0.7 logs (1 PS-ODN) to 1.25 logs (3 PS-ODNs) but had no effect on the growth of M. smegmatis , which does not export glutamine synthetase nor possess the poly- l -glutamate/glutamine (P- l -glx) cell wall structure. The experiments indicate that the antisense PS-ODNs enter the cytoplasm of M. tuberculosis and bind to their cognate targets. Although more potent ODN technology is needed, this study demonstrates the feasibility of using antisense ODNs in the antibiotic armamentarium against M. tuberculosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Cited by
Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence
Smith, I. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.463-496.2003 · Cited by 1,154
Bactericidal antisense effects of peptide–PNA conjugates
Good, L., Awasthi, S. K., Dryselius, R., Larsson, O., & Nielsen, P. E. (2001) · Nature Biotechnology · doi:10.1038/86753 · Cited by 391
The eukaryotic-like Ser/Thr protein kinases of Mycobacterium tuberculosis
Av-Gay, Y., & Everett, M. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01734-0 · Cited by 378
Delivery of antibiotics with polymeric particles
Xiong, M.-H., Bao, Y., Yang, X.-Z., Zhu, Y.-H., & Wang, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.002 · Cited by 302
Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target
Smith, R. S., & Iglewski, B. H. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320364 · Cited by 271
Cowley, S., Ko, M., Pick, N., Chow, R., Downing, K. J., Gordhan, B. G., Betts, J. C., Mizrahi, V., Smith, D. A., Stokes, R. W., et al. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04085.x · Cited by 254
Deol, P., Vohra, R., Saini, A. K., Singh, A., Chandra, H., Chopra, P., Das, T. K., Tyagi, A. K., & Singh, Y. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.10.3415-3420.2005 · Cited by 99
Reinhart, A. A., Powell, D. A., Nguyen, A. T., O'Neill, M., Djapgne, L., Wilks, A., Ernst, R. K., & Oglesby-Sherrouse, A. G. (2015) · Infection and Immunity · doi:10.1128/iai.02707-14 · Cited by 97
Metadata
- Authors
- Harth, G., Zamecnik, P. C., Tang, J.-Y., Tabatadze, D., & Horwitz, M. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-01-04
- Volume
- 97
- Issue
- 1
- Pages
- 418-423
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2043131595
- Cited by
- 131
- References
- 1
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.